Skip to main content

Nasopharengeal Pneumococcal Serotype Screening Assays: Completion, Testing, Validation, Scale-up and Market Launch

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 27, 2016
Award amount: 
$75,000
Organization name: 
f(x) Immune Diagnostics, Inc.
Principal Investigator: 
Hickey, Michael H.
Grant program category: 
Business Financing
Grant program name: 
Company Inception Loan
Region: 
Western

f(x) Immune Diagnostics, Inc. is developing novel diagnostic products to improve the surveillance, prevention, monitoring and treatment decisions related to pneumococcal pneumonia. The project will enable the company to complete development, validation and market launch of their pneumococcal serotyping screening assay.

Fiscal year: 
2016